INTRODUCTION
with no LPS injection at both 24 and 48 h post-LPS injection. Treatment with LPS increased IL-1β mRNA content (P = 0.01) in the group fed 0 mg of lutein. In the LPS injected groups, increasing dietary lutein to 50 mg decreased the IL-1β mRNA amount compared with the group fed 0 mg of lutein. In the LPS injected groups, increasing dietary lutein to 50 mg increased IL-10 mRNA content compared with the group fed 0 mg of lutein. Injection of LPS increased the thiobarbituric reactive substances content of the liver in the group fed 0 mg of lutein. Increasing dietary lutein to 50 mg decreased the thiobarbituric reactive substances content of the liver in the LPS injected groups. Dietary lutein supplementation decreased oxidative damage and inflammatory responses post-LPS injection by decreasing IL-1β production and increasing IL-10 production in turkeys.
following LPS injection (Ulich et al., 1992) . Dietary lutein supplementation decreases IL-1 mRNA at 2 h following an LPS injection in chickens . Lutein supplementation decreases IL-6 and several inflammatory parameters in the liver following an LPS injection in chickens (Meriwether et al., 2010) . Interluekin-10, an antiinflammatory cytokine, has a very little basal expression but is induced several fold at 24 h post-LPS treatment (Rothwell et al., 2004) . Lutein supplementation can be expected to reduce inflammatory parameters during an acute phase response, therefore improving production parameters in avians.
The effect of lutein supplementation on an acute phase response was studied in F-line turkeys. F-line turkeys are an experimental turkey line selected over 34 generations for increased 16-wk BW (Nestor et al., 2005) . F-line turkeys are more susceptible to challenge by Pasteurella multocida, a gram-negative bacteria, than commercial strains studied (Nestor et al., 1999) . Hence, we chose the F-line turkeys to study the effect of lutein supplementation during an acute phase response using LPS, a pathogen-associated molecular pattern specific to gram-negative bacteria. The effects of dietary lutein on BW gain, feed consumption, IL-1β, IL-10, and thiobarbituric reactive substances (TBARS), a measure of oxidative damage (Cherian et al., 2002) , were studied in F-line turkeys.
MATERIALS AND METHODS
Two experiments were conducted to study the effect of lutein supplementation during an LPS challenge in F-line turkeys. All animal protocols were approved by the Ohio Agricultural Research and Development Center animal care and use committee.
Experiment 1
Experiment 1 studied the effects of dietary lutein on mortality rate in F-line birds. A total of eighteen 1-d-old poults were randomly distributed to one of 2 dietary treatments (lutein at 0 or 50 mg/kg of feed). Each treatment was replicated in 3 pens of 3 poults/ replication. The basal diet was based on rice and soybean meal ( 
Experiment 2
The basal diet composition was the same as in experiment 1. Oro glo Dry was added to the above basal diet as a source of lutein to contribute 25 and 50 mg of lutein/kg of feed. A total of forty-eight 1-d-old poults were randomly distributed to one of 3 dietary treatments (lutein at 0, 25, or 50 mg/kg of feed) in 4 replications. All birds were weighed on d 50. Among the 4 birds in each replication, 2 birds were injected with Salmonella typhimurium LPS at 0.5 mg/kg of BW and 2 birds were not injected. At 6 h post-LPS injection, 2 birds from each replication, one injected with LPS and the other not injected with LPS (n = 4), were killed for collecting blood, liver, and spleen. The remaining 2 birds were transferred to individual floor pens for BW gain and feed consumption studies. Feed intake and BW gain were measured at 24 and 48 h post-LPS challenge. Blood, liver, and spleen were collected at 48 h post-LPS challenge. Plasma was collected from blood and stored at −80°C until further analysis. Liver and spleen were frozen immediately with liquid nitrogen and stored at −80°C until further analysis.
Lutein Analysis
Lutein was extracted (Koutsos et al., 2003b ) from approximately 1 g of liver, spleen, or feed or 1 mL of plasma samples and frozen at −80°C before HPLC analysis. The HPLC analysis (Waters 2796, Waters, Milford, MA) for lutein content was performed using a C18 reverse-phase column (3.5 μm, 4.6 mm i.d. × 150 mm length; X Bridge, Milford, MA). The isocratic mobile phase (100% methanol) was maintained at a flow rate of 1.0 mL/min, and automated injections of 50 μL were made. Absorbance at 445 was monitored using a photodiode detector (Waters 2998, Waters). Millenium software (Waters) was used to process and integrate peaks.
RNA Isolation, Real-Time PCR, and TBARS Assay
Total RNA was collected and reverse transcribed into cDNA (Selvaraj and Klasing, 2006) . The IL-10 was analyzed in samples collected at 48 h post-LPS injection, and IL-1β was analyzed in samples collected at 6 h post-LPS injection. The mRNA was analyzed for IL-10 (5′-catgctgctgggcctgaa-3′ and 5′-cgtctccttgatctgcttgatg-3′; Rothwell et al., 2004) and IL-1β (tcctccagccagaaagtga and caggcggtagaagatgaagc) mRNA by real-time PCR (iCycler, BioRad, Hercules, CA) using SyBr green after normalizing for β-actin mRNA (5′-accggactgttaccaacacc-3′ and 5′-gactgctgctgacaccttca-3′; Shanmugasundaram and Selvaraj, 2010) . The annealing temperature for IL-10 was 55°C, for IL-1β was 55°C, and for β-actin was 57°C. Fold change from the reference was calculated (Humphrey et al., 2004) as ES (Ct sample)/ER (Ct reference), where ES and ER are the sample and reference PCR amplification efficiencies as determined by LinRegPCR program (Ramakers et al., 2003) , and Ct is the threshold cycle. The Ct was determined by the iQ5 software (Biorad) when the fluorescence increases exponentially 2 fold times above background. The reference group was the group that had the lowest amount of expression of that particular cytokine. Liver TBARS content was analyzed using the QuantiChrom TBARS Assay Kit (BioAssay Systems, Hayward, CA) following the manufacturer's instructions.
Statistical Analysis
A 2-way ANOVA (JMP Software, Cary, NC) was used to examine the interactive and main effects of LPS and dietary lutein on the dependent variables. Interactions were removed when the observed P-value for interaction was greater than 0.20. When interaction (P < 0.20) or main effects were significant (P < 0.05), differences between means were analyzed by Tukey's least squares means comparison.
RESULTS

Experiment 1
The group with 50 mg of lutein supplementation had 1 mortality. The group with 0 mg of lutein had 4 mortalities at 48 h post-LPS injection.
Experiment 2
BW Gain and Feed Consumption. No significant differences (P > 0.05) were observed in BW between any of the dietary treatments on d 50. No mortality was observed in any of the treatment groups post-LPS injection. Both 24-and 48-h BW gain (P = 0.15 and P = 0.28, respectively) and feed consumption (P = 0.03 and P = 0.01, respectively) were influenced by interaction between LPS and dietary lutein content (Figures 1  and 2 ). In the groups fed 0 mg of lutein, LPS treatment decreased the BW gain and feed consumption at 24 and 48 h post-LPS injection. The BW gain of the group fed 50 mg of lutein in the LPS injected groups was comparable with that of the group with no LPS injection at both 24 and 48 h post-LPS injection. In the absence of LPS injection, dietary lutein did not influence BW gain. The effect of LPS on BW gain was partly through decreased feed consumption. The feed intake of the group fed 50 mg of lutein in the LPS injected groups was comparable to that of the group with no LPS injection at both 24 and 48 h post-LPS injection. Values are means ± SEM; n = 4. Means with no common letter differ. P-values from 2-way ANOVA for 24-h feed intake: LPS, P < 0.01; lutein, P = 0.09; LPS × lutein, P = 0.03. P-values from 2-way ANOVA for 24-to 48-h feed intake: LPS, P = 0.18; lutein, P = 0.45; LPS × lutein, P = 0.01.
Feed, Liver, and Plasma Lutein Content. The lutein content of the diet supplemented with 0 mg of lutein was <40 ng/kg of diet. The lutein content of groups supplemented with 25 and 50 mg of lutein was 26.6 and 50.6 mg of lutein/kg of diet, respectively. Both liver (P = 0.01) and plasma lutein (P = 0.02) contents were influenced by interaction between LPS and dietary lutein content (Figure 3 ). In the groups fed 50 mg of lutein, LPS treatment decreased the lutein content of both the liver and the plasma at 48 h post-LPS injection. Increasing dietary lutein increased the liver and plasma lutein content in both LPS injected and uninjected groups.
IL-1β and IL-10 mRNA Content. Both IL-1β (P = 0.11) and IL-10 (P = 0.01) contents of the spleen were influenced by interaction between LPS and dietary lutein content (Figures 4 and 5) . In the groups without LPS injection, increasing dietary lutein did not alter IL-1β mRNA content at 6 h post-LPS injection. Treatment with LPS increased IL-1β mRNA content (P = 0.01) in the group fed 0 mg of lutein. In the LPS injected groups, increasing dietary lutein to 50 mg decreased the IL-1β mRNA amount compared with the group fed 0 mg of lutein. In the absence of LPS treatment, increasing dietary lutein did not alter IL-10 mRNA content at 48 h post-LPS injection. In the LPS injected groups, increasing dietary lutein to 50 mg increased IL-10 mRNA content compared with the group fed 0 mg of lutein.
Liver and Plasma TBARS Content. Liver TBARS content was influenced by interaction (P < 0.01) between LPS and dietary lutein content (Figure 6 ). Injection of LPS increased the TBARS content of the liver in the group fed 0 mg of lutein. In the LPS injected groups, increasing dietary lutein to 50 mg decreased the TBARS content of the liver compared with the group fed 0 mg of lutein. Dietary lutein (P = 0.86), LPS injection (P = 0.42), and LPS × lutein interaction (P = 0.49) did not influence plasma TBARS content. Values are means ± SEM; n = 4. Means with no common letter differ. P-values from 2-way ANOVA for liver: LPS, P < 0.01; lutein, P < 0.01; LPS × lutein, P = 0.01. P-values from 2-way ANOVA for plasma: LPS, P = 0.01; lutein, P < 0.01; LPS × lutein, P = 0.02. Values are means ± SEM; n = 4. AU = arbitrary units. All bars represent fold increase or decrease compared with the group fed 0 mg of lutein and had no LPS injection. Means with no common letter differ. P-values from 2-way ANOVA: LPS, P = 0.01; lutein, P = 0.12; LPS × lutein, P = 0.11.
DISCUSSION
Two experiments were conducted to study the effect of dietary lutein supplementation during an acute phase inflammatory response in F-line turkeys. In the first experiment, dietary lutein supplementation at 50 mg/kg of diet decreased the mortality rate by approximately 30% compared with the group fed no dietary lutein. Hence, the second experiment was conducted with a lower dose of LPS than the first experiment so that live birds were available, in both the lutein-supplemented and the nonsupplemented groups, to study the mechanism through which dietary lutein supplementation acts to modify the host response post-LPS injection.
Dietary lutein supplementation increased the lutein content of both the liver and the plasma. Even the group that was not fed lutein had low levels of lutein in the liver and plasma. Turkey poults in the current experiment were hatched from eggs of breeder hens fed a corn-based diet that contained lutein. Yolk-derived carotenoids are conserved in chicks for at least 4 wk posthatch (Koutsos et al., 2003b) . Injection of LPS decreased the lutein content of the liver. The LPSinduced tissue lutein decrease might be attributable to partitioning of lutein to leukocytes, oxidation and metabolic losses, and increased excretion (Koutsos et al., 2003a) . Increasing dietary lutein content of LPSinjected birds partially increased the liver and plasma lutein contents.
Dietary lutein supplementation decreased the IL-1β mRNA content of the liver at 6 h post-LPS injection. Similarly, dietary lutein supplementation decreased IL-1β mRNA content in chicks . Lutein supplementation suppresses NFκb activation and decreases inflammatory mediators like nitric oxide, TNFα, IL-6, and prostaglandins (Jin et al., 2006) in mice; NFκb is a transcription factor involved in inflammatory response during an acute phase response and activated by inflammatory mediators and oxidative stress (Aktan, 2004) . Lutein, being an excellent antioxidant, reduces oxidative stress in avians (Hõrak et al., 2010) . In this experiment, LPS challenge increased the TBARS content of the liver, showing increased oxidative stress following LPS challenge. Dietary lutein supplementation prevented LPS-induced TBARS increase.
Lutein-supplemented birds had a higher BW gain at 24 h post-LPS injection. Differences in feed consumption contributed to the observed difference in BW gain. Injection of LPS decreased feed consumption. This effect of LPS on feed consumption is through increased inflammatory cytokine production. Inflammatory cytokines, particularly IL-1, decrease feed consumption during an LPS injection (Klasing et al., 1987) . In this experiment, dietary lutein supplementation decreased IL-1β production and increased IL-10 production post-LPS injection. Because IL-10 is an antiinflammatory cytokine, dietary lutein supplementation decreased inflammatory parameters and oxidative stress and increased antiinflammatory parameters to decrease the net effect of inflammation during an acute phase response.
Dietary lutein supplementation at 50 mg/kg of diet improved production parameters in F-line turkeys during an acute phase response by decreasing inflammatory parameters and improving oxidative status. The typical lutein content of turkey feed is <10 mg/kg of diet. Supplementing high-producing turkeys with lutein up to 50 mg/kg of feed may improve oxidative parameters and production parameters during an acute phase response.
